C
CYCCP
NOW TRADING POST CALL DATE
About this security
CYCCP is a 6% cumulative convertible perpetual preferred stock issued by Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock, a Healthcare issuer. $10 liquidation preference, current yield 11.88%, callable from 2007-11-06.
Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock: Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company that develops cancer medicines based on cell cycle, epigenetics, and mitosis biology, operating in the United States and the United Kingdom. Its lead programs include fadraciclib, a cyclin-dependent kinase (CDK) inhibitor in Phase 1/2 trials for solid tumors and hematological malignancies, and Plogosertib, a polo-like kinase inhibitor also in Phase 1/2 trials for advanced solid tumors and hematological malignancies. The company is small-cap, with a market capitalization of approximately $13.5 million. ↗
Issuer page — all Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock securities & profile →
Key Stats ✓ terms from SEC filing — verify via link below ✓ verified against SEC filing
vs. Healthcare category (1 issues): yield 11.88% vs avg 11.88% · discount -49.5% vs avg -49.5%
Quote
| CYCCP (preferred) | |
|---|---|
| Last | $5.05 |
| Change | — |
| Open | $5.05 |
| High / Low | $5.05 / $5.05 |
| Prev Close | — |
| Volume | — |
| 52-Week High / Low | $5.05 / $5.05 |
52-week range based on available history. Shares outstanding / market cap require a fundamentals feed (not in current data plan).
Price
Dividend History
No recent dividends — distribution may be suspended (check cumulative status) or newly issued.
Performance — $10K Calculator
Dividends reinvested (DRIP) at the close on each ex-date. Full performance page →